Guangzhou pharmaceutical industry frequently concocted Super Theme famous difficult character in fact

From deciphering the genome map of Salvia miltiorrhiza to the list of basic drugs in Russia, from the development of Chinese Medicine "anti-PA" against the super bacteria to win the "world's oldest pharmaceutical factory", from the implementation of the strategy to "China's first high price brand" ...　　Since June this year, in Guangzhou Pharmaceutical Industry (600332) issued a round of news shock Wave, the company's share price has risen steadily. From July 2 of 8.15 yuan/share to September 15 of 16.6 yuan/shares, a short period of two months, Guangzhou pharmaceutical shares rose 1 time times, and the same period prev close to 16%.　　And on the day of "9.11", Canton Pharmaceutical Group announced that it will launch the development of "Chinese medicine against the PA" to fight the world to hear the color of the super bacteria, and before the September 10, Canton Pharmaceutical counter market trading, after a trading day rose also up to 9.4%, the plate was once sealed in the trading board. However, in Guangzhou pharmaceutical industry these high-profile propaganda behind, what is the real situation? The Securities Times reporters have found that the publicity or the name is inconsistent, or exaggerated, or non-existent, and each speculation has caused a lot of doubt.　　Some brokerage researchers have even reminded investors to be wary of the investment traps behind high-profile speculation by big shareholders.　　The story behind "China's first brand" November 10, 2010, Canton Pharmaceutical Group in the "Wang Old Jida Health Industry development Planning press conference" High-profile announced: Wang Old Kat brand value of up to 108.015 billion yuan, far more than Haier previously set a record of 85.5 billion yuan, has become "China's first brand."　　What is the drug group's move to annoy the red Pot Wang old Kat belongs to add many treasure Group, Gado immediately issued a statement, said Red pot Wanglaoji production Enterprises Hung Road Group and Canton Pharmaceutical group without any affiliation, to the Canton Pharmaceutical Group to borrow the company's red pot Wanglaoji sales data and charitable donations to hype their own deep dissatisfaction. Wang Lao Ji as a kind of local herbal tea, early consumer market is basically confined to Guangdong. At the end of last century, Guangzhou pharmaceutical industry will be the red Pot Wanglaoji brand rights to rent to Hong Kong plus many treasure group, the operating situation just brilliant.　　Wang Old Kat brand is worth doubling today, all is thanks to Gado. Reporter investigation found a rather interesting thing, Wang old Gigon pot brand right is the former general manager of Guangzhou Pharmaceutical Li Yimin in office to rent to Hong Kong Gado, at that time, signed lease period from 1995 to 2020.　　It was then that the brand transfer Li Yimin dragged down the abyss of crime, and he was sentenced to heavy sentences for accepting huge bribes. Today, it seems that the Li Yimin also calculate the eye bead, did a good deed, because this transaction achieved a win-win situation, Canton Pharmaceutical industry, both Gado to do strong Wang old Kat brand, and the car to achieve their own green box Wanglaoji income.　　However, the face of red cans and green box in the profit of the difference, and let Guangzhou pharmaceutical industry throats, the heart is unhappy. According to industry insiders, now Hong Kong with the pharmaceutical industry and Canton pharmaceutical companies holding Canton Wang Old Kat Pharmaceutical Co., Ltd. 48.05% shares, while the former and Hong Kong Hung Road Group for the same actual control. After the expiry of the lease, Wanglaoji's brand makesIs the right to renew the lease Gado or another? Enjoys or ladder for a fraction of the profits?　　The game of both sides can only be seen. "The world's oldest pharmaceutical company" was questioned September 28, 2010, Guangzhou Baiyun International Convention Center held in Guangzhou Chen Lizi pharmaceutical company won the Guinness Book of World Records certified "The world's oldest pharmaceutical company" of the plaque ceremony, from the Guinness Book of World Records headquarters in London, Ms. Andreabanfi personally attended.　　According to the introduction, Canton Pharmaceutical subsidiary Chen Lizi Pharmaceutical company was founded in 1600 by the Guangdong South China Sea businessman Chen and Li Shen together in Guangzhou, has been 410 years of history, is still operating the world's oldest existing pharmaceutical companies. However, a domestic expert to study the "Old Chinese" experts on this question, that Guangzhou Chen Lizi pharmaceutical company even the most long-lived pharmaceutical companies can not say, not to mention the world's oldest pharmaceutical companies.　　At present, there are according to the domestic Chen Lizi, the history of the more long-standing pharmaceutical companies, the listed company has Xinhuang (600436) and Mayinglong (600993). The history of Xinhuang can be traced back to the year of 1555, when a court physician out of the palace in accordance with the Royal secret recipe Refining "Xinhuang" hanging pot, so far has been 450 years of history. Mayinglong's history dates back to the year of 1582, when Mayinglong's founder, Margindo, founded the Mayinglong Pharmacy and has a history of more than 428 years.　　The expert questioned how authoritative the so-called Guinness World Records are, and how often some domestic companies have been deeply puzzled by the grandstanding of "world first".　　Is the Chinese herbal anti-bully a "super Bluff"? September 11, 2010, Canton Pharmaceutical Group in Guangzhou Oriental Hotel held "Canton Pharmaceutical group anti-super bacteria drug research and development project" launch ceremony, Canton Pharmaceutical group general manager Li Chuyuan High-profile announced will spend 50 million yuan to carry out the fight against super bacteria "Chinese medicine against the PA" and other three special studies,　　And said this is a crisis in the world of medicine to the voice, is a heroic dry cloud. However, some experts in the Chinese medicine industry in China have poured cold water on this fever of medicine. In the forum after the ceremony, as a cooperative unit of Guangdong South China New Drug Creation Center deputy director, the Guangzhou Military General Hospital pharmacy Department Director Dr. Chang on the future of this study pessimistic.　　He said that the subject of research is understandable, but can not be in the emergence of super resistant Western medicine and Western medicine is helpless, the concept of traditional Chinese medicine to treat all diseases are rampant. Dr Chang says that, for the moment, what super bacteria are, the world is still foggy, the death of pathogenic microorganisms in different countries are the same species or different species are not clear, whether the super bacteria in the continuous mutation is not clear, can be said to be "Sanbuzhi",　　At this time the High-profile proposed the development of new Chinese medicine against super bacteria is clearly not in line with the scientific spirit. Chang also has a relationship with the units he serves, claiming that although the Canton Pharmaceutical group listed South China's new drug creation Center as a joint study of Chinese herbal anti-PAUnits, in fact they this center is only a member service organization, itself does not have the research and development strength, also does not engage in the new drug research and development. Chen Jiannan, a professor at Guangzhou University of Chinese Medicine at the same cooperation unit, advised: "As a company, catch some news hot hype to attract eyeballs can be understood." But the antibacterial and anti-inflammatory mechanism of traditional Chinese medicine is unknown at present. from the plate orchid root, and other natural plants to extract the active elements to develop broad-spectrum antibiotics, the amount of input, the time to how long, the probability of success, the risk of failure, from the perspective of the development of new drugs, to be carefully evaluated. Of course, it would be a different story if only to pursue a momentary sensation. "Guangzhou University of Chinese Medicine Wu Tsing and the Dean said a more tactful:" Canton Pharmaceutical Group of this topic is very creative, but Chinese medicine to inhibit the super bacteria, at present, it is indeed very difficult, where the drug, how to evaluate, have a considerable way to go. "Domestic well-known science experts, fight against the fighter Ark said, because the efficacy of traditional Chinese medicine, toxic side effects unknown, it is difficult to get the recognition of the international medical profession." In order to quantify the traditional Chinese medicine, the effective ingredient must be extracted. Ephedrine extracted from ephedrine and artemisinin extracted from Artemisia annua are among the few successful examples currently recognized. Several decades of research to obtain such two drugs, indicating that the development of new drugs from Chinese herbal medicine is not worth much.　　Chinese herbal medicine against "super bacteria" Haikou can boast, but in the International medical field will only laughable. Chinese herbal medicine enters Russia without any sense of Wonder July 24, 2010, in the first "Belarus Guangdong Science and Technology Festival", Guangzhou Pharmaceutical company announced that its subsidiary Qi Xing Pharmaceutical products Hua Tuo successfully entered the "Russian Basic drugs catalogue", and to obtain permanent approval of drug status.　　Guangzhou Pharmaceutical Industry For this is also a large number of local media in Guangzhou to advertise the soft text hype.　　In fact, it is not uncommon for Chinese medicine to enter the Russian market.　　According to the Russian Federation of pharmaceutical registered sales company General Manager Xiangyang, Chinese Medicine in Russia registration procedure is quite simple, Chinese medicine enterprises to enter the threshold of Russia is also very low, Chinese medicine in Russia registration as long as can prove that the drug contains ingredients non-toxic to the human body, do not need to explain what the effect of each ingredient In addition, the Chinese medicine to enter the Russian register is extremely inexpensive, only about RMB million, which and the United States, the European Union at a rate of hundreds of millions of registration fees are different.　　At present, more than 90% of Russian drugs rely on imports, but the vast majority of antibiotics, Chinese medicine in the Russian public hospital share can be said to be negligible. Ark Son said, domestic some Chinese medicine enterprise hype oneself how Yangwei overseas report, All is boast, self-deception. As far as he knows, European countries do not have the habit of taking Chinese medicine, domestic Chinese medicine products even enter these markets, will not achieve too much profit. If one day domestic Chinese medicine in the United States as a drug to obtain approval of the United States Food and Drug Administration (FDA), it is really a milestone significance. Because the United States has so far not approved any Chinese herbal medicine listing,Chinese herbal medicines sold in the United States are sold only as dietary supplements and will be severely penalized once they are advertised. The Genomic Atlas of Salvia miltiorrhiza Bunge June 20, 2010, Guangzhou Pharmaceutical holding shareholder Canton Pharmaceutical Group held a press conference in Beijing Diaoyutai National Guesthouse, a high-profile announcement of China's first medicinal plant Salvia miltiorrhiza Genome Map Sequencing, assembly completed, Canton Medicine will be the first to enter the genetic era of Chinese medicine.　　Li Chuyuan General manager said that the canton Pharmaceutical group will be based on the results of the genome Project, the opportunity to launch a comprehensive genome research to expand to its several key Chinese herbal enterprises, seize the Chinese Medicine science and technology and industrial chain source of the commanding heights. Some prominent experts in the domestic biology industry disagree.　　Ruchempin, chief science officer of Shenzhen Micro-Core Biotechnology Co., Ltd., said theoretically that it is important to use genes to study traditional Chinese medicine, but genetic sequencing is used for some identification of different varieties, and the identification of the same species does not have to be done in this way, which is of little practical significance. A professor of biology at Sun Yat-sen University has questioned this, and believes that although the Canton Pharmaceutical Group is a large Chinese herbal enterprise, there are few specialists in genetics and genetic engineering, and there is no ability to carry out genetic research. Moreover, the mainstream of the international biology Community does not endorse the term "gene of Chinese Medicine".　　Although gene sequencing is helpful to the identification of drugs, there are already conventional methods of identification in the market, and the research of the Canton Pharmaceutical Group is superfluous. In response to the Guangzhou pharmaceutical industry constantly hype the news theme of the move, the industry researcher of a securities company in Guangzhou commented: "Listed companies frequently hype subject matter to attract investors, if there is really anything fishy, generally there are a number of situations: first, the large shareholder to reduce their own set or with institutional investors high off Second, in order to launch timely financing plans, the third is to promote brand awareness, expand the market share of products. As a listed company, especially for the Guangzhou pharmaceutical industry in the case of the high level of corruption and commercial bribery scandals of enterprises, the key or should be focused on the corporate governance structure, do a good job. Spend huge sums of money to hype some not much practical significance of the subject matter, on the company's brand reputation and sales performance of how much help, it is difficult to judge.